vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.
MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $38.3M, roughly 1.8× ImmunityBio, Inc.). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs -161.8%, a 179.1% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 25.4%).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
IBRX vs MFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $38.3M | $70.6M |
| Net Profit | $-61.9M | $12.2M |
| Gross Margin | 99.0% | — |
| Operating Margin | -169.0% | 29.3% |
| Net Margin | -161.8% | 17.3% |
| Revenue YoY | 407.0% | 25.4% |
| Net Profit YoY | -4.7% | 20.3% |
| EPS (diluted) | $-0.06 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $70.6M | ||
| Q3 25 | $32.1M | $58.7M | ||
| Q2 25 | $26.4M | $62.6M | ||
| Q1 25 | $16.5M | $63.0M | ||
| Q4 24 | $7.6M | $56.3M | ||
| Q3 24 | $6.1M | $53.3M | ||
| Q2 24 | — | $51.0M | ||
| Q1 24 | — | $53.3M |
| Q4 25 | $-61.9M | $12.2M | ||
| Q3 25 | $-67.3M | $7.8M | ||
| Q2 25 | $-92.6M | $11.1M | ||
| Q1 25 | $-129.6M | $12.0M | ||
| Q4 24 | $-59.2M | $10.1M | ||
| Q3 24 | $-85.7M | $8.6M | ||
| Q2 24 | — | $7.1M | ||
| Q1 24 | — | $10.0M |
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -169.0% | 29.3% | ||
| Q3 25 | -173.5% | 33.2% | ||
| Q2 25 | -269.8% | 31.1% | ||
| Q1 25 | -390.1% | 32.1% | ||
| Q4 24 | -919.0% | 32.8% | ||
| Q3 24 | -1314.3% | 26.6% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 33.6% |
| Q4 25 | -161.8% | 17.3% | ||
| Q3 25 | -209.8% | 13.2% | ||
| Q2 25 | -350.3% | 17.7% | ||
| Q1 25 | -784.9% | 19.1% | ||
| Q4 24 | -783.4% | 18.0% | ||
| Q3 24 | -1404.0% | 16.1% | ||
| Q2 24 | — | 13.9% | ||
| Q1 24 | — | 18.8% |
| Q4 25 | $-0.06 | $0.50 | ||
| Q3 25 | $-0.07 | $0.32 | ||
| Q2 25 | $-0.10 | $0.46 | ||
| Q1 25 | $-0.15 | $0.50 | ||
| Q4 24 | $-0.08 | $0.43 | ||
| Q3 24 | $-0.14 | $0.37 | ||
| Q2 24 | — | $0.30 | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $136.3M |
| Total DebtLower is stronger | — | $216.0M |
| Stockholders' EquityBook value | $-500.5M | $408.6M |
| Total Assets | $501.9M | $3.0B |
| Debt / EquityLower = less leverage | — | 0.53× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $136.3M | ||
| Q3 25 | $257.8M | $72.5M | ||
| Q2 25 | $153.7M | $110.4M | ||
| Q1 25 | $61.6M | $131.5M | ||
| Q4 24 | $149.8M | $98.2M | ||
| Q3 24 | $130.4M | $120.6M | ||
| Q2 24 | — | $87.7M | ||
| Q1 24 | — | $54.8M |
| Q4 25 | — | $216.0M | ||
| Q3 25 | — | $215.7M | ||
| Q2 25 | — | $199.9M | ||
| Q1 25 | — | $199.7M | ||
| Q4 24 | — | $232.2M | ||
| Q3 24 | — | $232.0M | ||
| Q2 24 | — | $230.8M | ||
| Q1 24 | — | $225.6M |
| Q4 25 | $-500.5M | $408.6M | ||
| Q3 25 | $-524.3M | $397.4M | ||
| Q2 25 | $-570.7M | $389.9M | ||
| Q1 25 | $-591.4M | $380.2M | ||
| Q4 24 | $-489.1M | $370.2M | ||
| Q3 24 | $-745.1M | $362.4M | ||
| Q2 24 | — | $354.0M | ||
| Q1 24 | — | $349.0M |
| Q4 25 | $501.9M | $3.0B | ||
| Q3 25 | $519.0M | $2.9B | ||
| Q2 25 | $402.1M | $2.9B | ||
| Q1 25 | $303.8M | $2.8B | ||
| Q4 24 | $382.9M | $2.9B | ||
| Q3 24 | $364.6M | $2.9B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.65× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $126.3M |
| Free Cash FlowOCF − Capex | $-71.3M | — |
| FCF MarginFCF / Revenue | -186.2% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | 10.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $126.3M | ||
| Q3 25 | $-68.9M | $67.0M | ||
| Q2 25 | $-79.7M | $-10.7M | ||
| Q1 25 | $-85.9M | $36.3M | ||
| Q4 24 | $-85.1M | $108.7M | ||
| Q3 24 | $-98.8M | $24.6M | ||
| Q2 24 | — | $27.6M | ||
| Q1 24 | — | $32.3M |
| Q4 25 | $-71.3M | — | ||
| Q3 25 | $-69.6M | — | ||
| Q2 25 | $-80.8M | — | ||
| Q1 25 | $-87.0M | — | ||
| Q4 24 | $-87.3M | — | ||
| Q3 24 | $-101.6M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -186.2% | — | ||
| Q3 25 | -217.2% | — | ||
| Q2 25 | -305.9% | — | ||
| Q1 25 | -526.9% | — | ||
| Q4 24 | -1155.4% | — | ||
| Q3 24 | -1663.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 28.0% | — | ||
| Q3 24 | 45.7% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 10.35× | ||
| Q3 25 | — | 8.63× | ||
| Q2 25 | — | -0.97× | ||
| Q1 25 | — | 3.02× | ||
| Q4 24 | — | 10.72× | ||
| Q3 24 | — | 2.86× | ||
| Q2 24 | — | 3.89× | ||
| Q1 24 | — | 3.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.